2024 Investor Day · page 75 of 109
The slide highlights two key innovation areas: Metachromatic Leukodystrophy (MLD) and Next Generation Sequencing (NGS) for newborn screening.
Consulting deck · initiative_list · present_solution · dense density
Slide locked Sign in to view
Slide schematic 6/7
callout 1/2 list 2/2 paragraph 1/1 source-note 1/1 title 1/1
1 without position callout 1
callout
Components 7
primary callout bullet bullet paragraph source-note headline
Tools 0
∅
No tools
No canon tool match is anchored to this slide.
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 0
∅
No frameworks
No framework match is anchored to this slide.